Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
02/08/20112:07PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:IMGNImmunoGen Inc
02/04/20112:44PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:IMGNImmunoGen Inc
02/01/20115:30AMBusiness WireImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 25, 2011NASDAQ:IMGNImmunoGen Inc
01/27/20113:07PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IMGNImmunoGen Inc
01/27/20113:01PMBusiness WireImmunoGen, Inc. Reports Second Quarter Fiscal Year 2011 Financial ResultsNASDAQ:IMGNImmunoGen Inc
01/20/201110:05AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMGNImmunoGen Inc
01/20/20115:30AMBusiness WireImmunoGen, Inc. Announces Conference Call to Discuss its Second Quarter Fiscal Year 2011 Financial ResultsNASDAQ:IMGNImmunoGen Inc
01/18/20118:14AMBusiness WireImmunoGen, Inc. Appoints Theresa Wingrove, Ph.D., as Vice President, Regulatory AffairsNASDAQ:IMGNImmunoGen Inc
01/03/20118:13AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/03/20118:12AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/03/20115:30AMBusiness WireImmunoGen, Inc. Announces Webcast of Presentation at J.P. Morgan 29th Annual Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
12/23/20108:39AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IMGNImmunoGen Inc
12/10/20106:32PMDow Jones NewsImmunogen-Roche Breast-Cancer Drug Has Positive Response In Early TrialNASDAQ:IMGNImmunoGen Inc
12/10/20105:30PMBusiness WireImmunoGen, Inc. Announces Clinical Data for T-DM1 Used in Combination with Pertuzumab for First-Line Treatment of HER2+ Metas...NASDAQ:IMGNImmunoGen Inc
12/04/20104:30PMBusiness WireImmunoGen, Inc. Announces Presentation of Positive Initial Clinical Data for IMGN901 Used in a Combination Regimen for Multip...NASDAQ:IMGNImmunoGen Inc
12/03/20107:44AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IMGNImmunoGen Inc
11/30/20105:30AMBusiness WireImmunoGen, Inc. Announces Initiation of Randomized Clinical Trial Evaluating IMGN901 for First-Line Treatment of Small-Cell L...NASDAQ:IMGNImmunoGen Inc
11/23/20102:42PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)NASDAQ:IMGNImmunoGen Inc
11/23/20102:42PMEdgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)NASDAQ:IMGNImmunoGen Inc
11/19/20105:31AMBusiness WireImmunoGen, Inc. Announces Presentation of Encouraging Clinical Data for IMGN388 at EORTC-NCI-AACR Symposium on Molecular Targ...NASDAQ:IMGNImmunoGen Inc
11/18/201011:56AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IMGNImmunoGen Inc
11/18/20108:05AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/18/20108:05AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/18/20108:05AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/18/20108:04AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/18/20108:04AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/18/20108:04AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/18/20108:03AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/18/20108:03AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMGNImmunoGen Inc
11/17/20105:31AMBusiness WireImmunoGen, Inc. Announces Clinical Data Presentations at the 52nd ASH Annual Meeting and ExpositionNASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN